Women show cognitive advantage in gender-equal countries

Women’s cognitive functioning past middle age may be affected by the degree of gender equality in the country they live in, according to new findings from Psychological Science, a journal of the Association for Psychological Science.

“This research is a first attempt to shed light on important, but understudied, adverse consequences of gender inequality on women’s health in later life,” explains researcher Eric Bonsang of University Paris-Dauphine and Columbia University, lead author on the study. “It shows that women living in gender-equal countries have better cognitive test scores later in life than women living in gender-unequal societies. Moreover, in countries that became more gender-equal over time, women’s cognitive performance improved relative to men’s.”

Bonsang and colleagues Vegard Skirbekk (Norwegian Institute of Public Health and Columbia University) and Ursula Staudinger (Columbia University) had noticed that the differences in men’s and women’s scores on cognitive tests varied widely across countries. In countries in Northern Europe, for example, women tend to outperform men on memory tests, while the opposite seems to be true in several Southern European countries.

“This observation triggered our curiosity to try to understand what could cause such variations across countries,” says Bonsang.

While economic and socioeconomic factors likely play an important role, Bonsang, Skirbekk, and Staudinger wondered whether sociocultural factors such as attitudes about gender roles might also contribute to the variation in gender differences in cognitive performance around the globe. They hypothesized that women who live in a society with more traditional attitudes about gender roles would likely have less access to opportunities for education and employment and would, therefore, show lower cognitive performance later in life compared with men of the same age.

The researchers analyzed cognitive performance data for participants between the ages of 50 and 93, drawn from multiple nationally representative surveys including the US Health and Retirement Study; the Survey of Health, Ageing and Retirement in Europe; the English Longitudinal Study of Ageing; and the World Health Organization Study on Global AGEing and Adult Health. Together, the surveys provided data for a total of 27 countries.

All of the surveys include an episodic memory task to measure cognitive performance. Participants heard a list of 10 words and were asked to recall as many as they could immediately; in some of the surveys, participants again recalled as many words as they could after a delay. Additionally, some of the surveys included a task intended to assess executive function in which participants named as many animals as they could within 1 minute.

To gauge gender-role attitudes, the researchers focused on participants’ self-reported agreement with the statement, “When jobs are scarce, men should have more right to a job than women.”

Overall, the data showed considerable variability in gender differences in cognitive performance across countries. In some countries, women outperformed men–the female advantage in cognitive performance was highest in Sweden. In other countries, however, men outperformed women–the male advantage was highest in Ghana.

As the researchers hypothesized, increasingly traditional gender-role attitudes were linked with decreasing cognitive performance among women across countries. In other words, women in countries with less traditional attitudes were likely to have better cognitive performance later in life relative to women in more traditional countries.

Bonsang and colleagues noted that changes in gender-role attitudes within a country over time were associated with changes in women’s cognitive performance relative to men.

Although the data are correlational in nature, several more detailed analyses point toward a causal relationship. These analyses suggest that gender-role attitudes may play a notable role in important outcomes for women across different countries, the researchers argue.

“These findings reinforce the need for policies aiming at reducing gender inequalities as we show that consequences go beyond the labor market and income inequalities,” says Bonsang. “It also shows how important it is to consider seemingly intangible influences, such as cultural attitudes and values, when trying to understand cognitive aging.”

“In future work, we plan to disentangle the effect of gender-role attitudes on gender difference in cognition–via the impacts of those attitudes on institutions, politics and labor market characteristics–from the impact of beliefs of women associated with gender-role attitudes,” Bonsang says.

Flax Seeds Help Women Most: Study

Flaxseed is the new sought-after supplement in faily diet owing to its component lignans which help women to get regular menstrual cycle and also reduce the risk of breast cancer, show recent research findings.

According to the American Institute for Cancer Research, flax seed contains lignans, also called phytoestrogens, bearing a chemical structure similar to estrogen but unlike estrogen that increases the risk of breast cancer, these brown seeds do not increase cancer risk but be more protective.

In studies conducted on animals, it was shown that lignans isolated from flaxseed help women during the menstrual period and post-menopausal period by lowering the risk of breast cancer. It was also observed that flaxseed did not interfere with the effectiveness of the anti-estrogen medication tamoxifen, said the AICR study. The higher blood levels of lignans show prominent cancer-protective features, said the study.

“For people who wish to consume flaxseed as a source of omega-3 fat or dietary fiber, studies do not support fears that flaxseed could increase incidence or recurrence of breast cancer,” says Karen Collins. However, more research is to be done before recommending it as a medication for breast cancer, said Collins in the paper.

In a previous study conducted from 2002 to 2005, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) researchers used the MARIE study to take blood samples of 1,140 women who had been diagnosed with postmenopausal breast cancer. After a mean observation time of six years, they related enterolactone levels to clinical disease progression.

Compared to the study subjects with the lowest enterolactone levels, the women with the highest blood levels of this biomarker had an approximately 40 percent lower mortality risk. When the scientists additionally took account of the incidence of metastasis and secondary tumors, they obtained a similar result: Women with the highest enterolactone levels also had a lower risk for such an unfavorable disease progression.

“We now have first clear evidence showing that lignans lower not only the risk of developing postmenopausal breast cancer, but also the mortality risk,” said Jenny Chang-Claude.

There had been prior studies to determine the lignan intake by means of dietary surveys. But the results of such surveys are often unreliable and, in addition, there are big differences in the way individuals actually process the plant substances into effective metabolic products. Therefore, the Heidelberg team chose the more reliable measurement of biomarkers.

Otherwise, flax seeds have other potential medicinal properties, besides preventing growth of harmful cancer cells, even for prostate cancer. Since these seeds are found to catalyze insulin secretion in the body to regulate blood-sugar levels, diabetics are often advised to make it part of their daily diet.

In menopausal women, flaxseeds help them fight complications by maintaining balance in body hormones and reducing the risk of osteoporosis. It is also helpful in lowering bad cholesterol due to its rich nutrients.

The flipside of flaxseeds is that they are rich in calorie levels, 150 grams in four tablespoons.

Life Expectancy: Indian women live longer than men

Life expectancy has escalated to a great extent since 1990 as people even in poor nations are living longer than ever, though many of them struggling with sickness and age-old ailments, finds a new study.

In India, between 1990 and 2013, life expectancy for men and women has elevated by 6.9 years and 10.3 years, respectively.

Photo Credit: Pedro Ribeiro Simões

This new study was conducted in 188 countries by an international research team working on a project called “Global Burden of Disease” and headed by Institute for Health Metrics and Evaluation (IHME) at the University of Washington.

Owing to the deterioration of mortality and illness rates due to HIV/AIDS and malaria in the last ten years, health has enhanced to a great deal across the globe. Apart from this, meeting contagious, maternal, newborn and nutritive conditions, effectively has also added to the enhancement.

Nevertheless, healthy life expectancy (HALE) at birth hasn’t seen much improvement, thus; making those who live longer live sicker.

Theo Vos, the professor of IHME as well as who lead the study said albeit health has seen a global advancement it’s time that “more effective ways” to treat and combat disorders and diseases are discovered.

The study discovered that global life expectancy and healthy life expectancy for both genders escalated by 6.2 years and 5.4 years, respectively. However, in comparison to the life expectancy that increased from 65.3 in 1990 to 71.5 in 2013, healthy life expectancy didn’t see a drastic leap with 56.9 in 1990 to 62.3 in 2013.

Majority of the evaluated nations showed “significant and positive” healthy life expectancy changes. However, Belize, Botswana and Syria didn’t show drastic changes in HALE in 2013 as compared to 1990 with the first two nations, showing regression of 2 and 1.3 years, respectively.

In other cases, countries like Paraguay, Belarus and South Africa saw a deterioration in healthy life expectancy. For instance, places like Swaziland and Lesotho in Africa and South Africa, respectively, saw healthy life expectancy drop in individuals born in 2013 as compared to them who were born 20 years before.

People of Cambodia and Nicaragua showed gripping escalation between 1990 and 2013 with 13.9 and 14.7 years, respectively.

Nonetheless, Ethiopia was pin-pointed as one of the nations that have been giving massive efforts to make sure that their country people live both healthier and longer. For instance, in 1990, the healthy life expectancy of an Ethiopian was 40.8 years, but by 2013 with 13.5 years leap, it saw over a two-fold increase to 54.3 years.

Christopher Murray, who is the IHME director said albeit “income and education” play important roles in ensuring proper health, it doesn’t “tell the full story,” adding that weighing both healthy life expectancy and health loss on each sides at country level will facilitate “guide policies” in ensuring longer and healthier lives in every nook and cranny of the world.

Italy, Spain, Norway, Switzerland and Israel showed the lowest rates of health loss. With 42 years, in 2013, Lesotho recorded the lowest healthy life expectancy whereas with 73.4 years, Japan recorded the highest healthy life expectancy.

The findings have been published in the August 27 issue of the journal “The Lancet”.

According to the World Health Organization (WHO), Europe showed stagnation in showing better life expectancy during the 1990s, but after 1990 when life expectancy increased by 6 years around the world, Europe also saw some increase.

On the other hand, African nations have been showing a drop in life expectancy due to being plagued by HIV/AIDS, but now with the accessibility of antiretroviral therapy, the rates have seen an escalation. For instance, in 2000, standard life expectancy at birth was 50 years, but it saw an 8 year leap in 2013.

WHO further informed that high-income nations showed greater life expectancy at 60 years of age with expectation of the individual, living another 23 years in comparison to low-income and lower-middle income nations, which showed 17 more years of life expectancy.